Form4insider filings, from the source

SEC Form 4 · accession 0001144204-18-029351

Cytosorbents Corp · CTSO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kathleen P. Bloch
Officer — Chief Financial Officer
Period of report
May 15, 2018
Accepted (ET)
May 16, 2018 · 9:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 15, 2018M12,400$4.69A265,704D
Common StockF2May 15, 2018S12,400$8.75D253,304D
Common StockF3holding———9,000ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)$4.69May 15, 2018M12,400DJan 30, 2017Jun 7, 2026Common Stock12,40012,400D

Explanation of responses